Renee Ferris is a seasoned finance leader with over two decades of experience driving strategic financial leadership at global multi-billion-dollar healthcare companies. Known for her passionate and pragmatic approach, she leads with integrity focusing on what is best for the business and the people (colleagues and customers). Renee brings a robust track record in leading financial transformations, M&A strategy, commercial P&L management, and system implementation.
Previous to joining Javara, Renee held leadership roles at Haleon (IPO spinoff of GSK’s consumer healthcare portfolio), where she led the financial strategy for the Vitamins, Minerals & Supplements & Marketing Services categories. Her contributions included shaping the investor relation narrative, leading category strategy and M&A planning.
Renee started her corporate finance career at Pfizer Consumer Healthcare (formerly Wyeth), rising through the ranks to Director of Brand & Commercial Finance. There she managed portfolios exceeding $1.2 billion in revenue driving consistent revenue and market share growth while increasing profit by $100 million. Prior to her role on brands, she was on the Global Innovation & M&A teams where $500 million in net sales was generated from the deals closed during her tenure (including the acquisition of Emergen-C and the OTC licensing deal of Nexium 24Hr).
She holds both a BS and MBA in Finance from Fairleigh Dickinson University where she was a presidential scholar and standout collegiate athlete. In addition to her corporate finance achievements, Renee has served as an adjust professor of finance and worked in sales for 2 years.
